-The Times of India MUMBAI: Here's why drug-resistant tuberculosis (TB) breeds freely in Mumbai: Patients don't get appropriate medication. A new study collating information from eight hospitals and treatment centres across Mumbai, Thane and Navi Mumbai found patients were given drugs that they were resistant to. The study, published in PLOS ONE medical journal recently, looked at 340 patients suffering from multi-drug resistant (MDR) TB between 2005 and 2013. "We found only 29.4% of...
More »SEARCH RESULT
Total Matching Records found : 977
Flu in the air -M Sai Gopal
-The Hindu Public health experts agree that the response to the pandemic depends on constant surveillance and monitoring the evolution of the viral strain A viral storm is raging across the country. More than 200 deaths due to Influenza A (H1N1), known as swine flu, have been recorded within a short period of over a month. Telangana, has the dubious distinction of recording over 50 deaths and more than 600 H1N1-positive cases...
More »Medicines in India, for India -Pavan Srinath
-The Hindu Tropical diseases have often been neglected by pharmaceuticals because the size of the drug market is smaller, people have lower incomes and companies are uncertain about IPR January marked an important breakthrough in the fight against tropical diseases. Researchers and the International Centre for Genetic Engineering and Biotechnology (ICGEB) in Delhi found a drug candidate that prevented TB and malaria pathogens from infecting human blood cells. It is not just that...
More »Govt to sell 504 drugs under 'Jan Aushadhi' -Sushmi Dey
-The Times of India NEW DELHI: From July 1, you can walk up to a chemist and ask for a 'Jan Aushadhi' brand for your medicine, with the government set to launch its own brand to sell low cost generic medicines. The Centre will procure medicines in bulk from public as well as private drug manufacturing firms and rebrand them under 'Jan Aushadhi'. These will be sold in the retail market at...
More »Patented drug price
-PTI New Delhi: The drug price regulator has sought details of patented medicines as part of a drive to fix their rates. The National Pharmaceutical Pricing Authority (NPPA) is also fixing the price ceiling for 102 drugs on the National List of Essential Medicines (NLEM) and has asked for financial data, like retail rates and the firms' turnover. On patented drugs imported or manufactured for sale in India, the NPPA has called for...
More »
